Windlas Biotech Ipo Gmp | The issue is priced at ₹448 to ₹460 per equity share. Incorporated in 2001, windlas biotech ltd. Read windlas biotech limited ipo alongside company data with pros and cons of investing with grey market price in comments, article published in initial public offering section on e akhabaar. Verify value band, gmp and different particulars. Windlas biotech ipo windlas biotech ltd is one of the leading companies in the pharmaceutical formulations contract development and strength of windlas biotech.

Any anchor bookings that might take place would happen on august 3, before the opening day. As per market observers, devyani international shares are available at as strong premium (gmp) of ₹150 in the grey market. The promoter of this company is mr. Windlass biotech, maker of the pharmaceutical formulation's preliminary public providing (ipo), opened for public subscription on august 4. Windlas biotech ipo grey market premium is as follows and you can check gmp of other ipos as well from links given manoj kumar windlass.

Incorporated in 2001, windlas biotech ltd. The company windlas biotech announced its initial public offer to raise huge capital for the upcoming growth to achieve new goals. Manoj kumar windlass, and akw wbl family private trust are the promoters gmp for windlas biotech ipo is not known as there are no trades yet. The ipo contains situation of fairness shares price rs 165. Windlas biotech limited, one of the leading domestic pharmaceutical formulations cdmo will open its ipo on august 4th to august 6th 2021. Windlas biotech ipo comprises fresh issuance of equity shares worth ₹165 crore and an offer for sale of up to 5,142,067 equity shares. Windlas biotech limited is going public with its initial public offering (ipo) on august 4 and it will close its subscription on august 6. Find ipo date, price, live subscription, allotment, grey market premium gmp, listing date, analysis and review. View windlas biotech ltd ipo synopsis for forthcoming ipo issue, open ipo issue, close ipo issue and new listing on both bse/nse stock exchanges. Windlass biotech, maker of the pharmaceutical formulation's preliminary public providing (ipo), opened for public subscription on august 4. Strong focus on the chronic therapeutic. Get details like windlas biotech ipo gmp, review, price, listing date, allotment, financials, subscription, broker view, peer comparison. Initial public offer of up to * equity shares of face value of (rs)5 each (equity shares) of windlas biotech ltd (company for cash at a price of.

The company windlas biotech announced its initial public offer to raise huge capital for the upcoming growth to achieve new goals. 3 windlas biotech (ipo) listing date. Check out the gmp of other ipos. Windlas biotech limited is going public with its initial public offering (ipo) on august 4 and it will close its subscription on august 6. Incorporated in 2001, windlas biotech ltd.

Verify value band, gmp and different particulars. Windlas biotech is among the top five contract developers and manufacturers for pharmaceutical companies, according to crisil. The windlas biotech ipo gmp is not out yet as the grey market for this ipo will be opening soon so stay tuned. Any anchor bookings that might take place would happen on august 3, before the opening day. Business news › markets › ipos/fpos › windlas biotech files draft papers for ipo. Moreover, it has big clients in pfizer, sanofi india, cadila healthcare, emcure pharmaceuticals, eris lifesciences. Windlas biotech limited is going public with its initial public offering (ipo) on august 4 and it will close its subscription on august 6. Initial public offer of up to * equity shares of face value of (rs)5 each (equity shares) of windlas biotech ltd (company for cash at a price of. As per market observers, devyani international shares are available at as strong premium (gmp) of ₹150 in the grey market. Watch the interrogation with windlas biotech's managing director hitesh windlass Get windlas biotech ipo details. Get windlass biotech ipo details,updates of grey market premium, gmp,find ipo ,price,analysis,live subscription, allotment, listing windlas biotech company details windlass is amongst the top five players in the domestic pharmaceutical formulations. Manoj kumar windlass, and akw wbl family private trust are the promoters gmp for windlas biotech ipo is not known as there are no trades yet.

The company windlas biotech announced its initial public offer to raise huge capital for the upcoming growth to achieve new goals. Moreover, it has big clients in pfizer, sanofi india, cadila healthcare, emcure pharmaceuticals, eris lifesciences. Windlass biotech, maker of the pharmaceutical formulation's preliminary public providing (ipo), opened for public subscription on august 4. Get windlass biotech ipo details,updates of grey market premium, gmp,find ipo ,price,analysis,live subscription, allotment, listing windlas biotech company details windlass is amongst the top five players in the domestic pharmaceutical formulations. Windlas, krsnaa diagnostics, devyani, exxaro ipo opens immediately:

(i) it is amongst the top five players in the domestic pharmaceutical formulations contract development and. Windlass biotech, maker of the pharmaceutical formulation's preliminary public providing (ipo), opened for public subscription on august 4. Strong focus on the chronic therapeutic. The company windlas biotech announced its initial public offer to raise huge capital for the upcoming growth to achieve new goals. The grey market premium (gmp) for the windlas biotec. The grey market is an unofficial platform. Find ipo date, price, live subscription, allotment, grey market premium gmp, listing date, analysis and review. The company is into domestic pharmaceutical formulations contract development and manufacturing business. Windlas biotech limited, one of the leading domestic pharmaceutical formulations cdmo will open its ipo on august 4th to august 6th 2021. The estimated listing price for windlas biotech ipo is ₹610 which is approx 32.61% gain. The issue is priced at ₹448 to ₹460 per equity share. Moreover, it has big clients in pfizer, sanofi india, cadila healthcare, emcure pharmaceuticals, eris lifesciences. Manoj kumar windlass, and akw wbl family private trust are the promoters gmp for windlas biotech ipo is not known as there are no trades yet.